PROVIDER FILE · Questions worth asking

Found Review: Questions to Settle Before Choosing a Weight-Care Plan

Found documents branded and compounded GLP-1 options, oral alternatives and app-based support. The practical challenge is identifying which medicine, care arrangement and billing terms apply to your enrollment.

Before enrolling with Found, ask for one written description of your proposed plan: the medication and presentation, who provides care, what is charged today, and what happens next. Found’s public documentation describes several different arrangements, not one interchangeable subscription. A compounded-medication package, a branded-prescription membership and an insurance-supported care plan can have different inclusions and responsibilities. Their advertised monthly figures do not necessarily describe the same purchase.

Found presents itself as an online weight-management program offering personalized clinical care, medication options and behavioral support. This review examines its public documentation consulted October 19, 2026, rather than firsthand treatment. The central question is not simply whether Found offers GLP-1 treatment—it does—but whether a prospective member can identify the applicable offer before paying. Several pages provide useful detail; others leave meaningful differences over prepayment, Medicare and branded-medication pricing unresolved.

At a glance

Documented treatment options
Found lists branded GLP-1 medicines, compounded injectable semaglutide and tirzepatide, and a separate non-GLP-1 oral-generics plan.
Sources: [12] [10] [9] [5]
Billing interval
Offer terms describe prices billed every four weeks, or 28 days. The commercial pricing page conditions its lowest advertised prices on 12-month plans paid upfront.
Sources: [10] [12]
Insurance visits
Insurance-supported care requires synchronous video visits, including before refills, with a separate visit copay described as typically around $30.
Sources: [13]
Branded medication costs
Found’s branded GLP-1 plan includes prescription services and membership, but medication is billed separately.
Sources: [10]
Renewal exposure
Renewal payments are nonrefundable. Found recommends canceling or pausing at least 48 hours before the scheduled renewal charge.
Sources: [10]

Start by identifying the plan, not the headline price

Found’s offerings span materially different purchases. Its compounded GLP-1 terms include clinical care, medication and membership. The branded GLP-1 plan includes prescription services and membership but excludes the medicine itself. A separate generics plan includes prescription services, non-GLP-1 oral medication and membership. Ask the enrollment team to name the exact plan and identify every component before comparing its price with another service. Our medication questions guide provides a framework for separating the medicine from the surrounding package.

The medication catalog advertises Ozempic at $1,100 per month, Wegovy starting at $650 per month plus, Zepbound starting at $650 per month plus, and Mounjaro at approximately $1,100 per month. That catalog block does not fully specify supply or purchase conditions. Other comparison tables show Wegovy at $149–$349 per month and Zepbound at $299–$449 per month, subject to cash payment and multimonth plans. The consulted documentation does not reconcile presentation, promotion or pharmacy-channel differences.

Found also advertises a compounded injectable semaglutide “microdosing” program. Its page says prescriptions require evaluation by a licensed provider and clinical appropriateness; complete admission criteria and prices were not established. Do not assume this offer is interchangeable with the standard compounded plan. Ask which formulation, route, presentation and prescribing rationale are proposed, and whether the quoted membership and medicine charges belong to that specific offer.

Sources: [12] [10] [6] [9]

Ask what will actually leave your account

The table below preserves the regular compounded-plan rates published in Found’s terms. Each entry is an advertised monthly amount billed on a 28-day cycle, not a calendar-month charge. Found says these packages include clinical care, compounded medication and membership. Applicable laboratory testing and branded GLP-1 medicines are excluded. Insurance-related copays, coinsurance and deductibles can remain additional, so “all-in” should not be read as a promise that every possible expense is covered.

There is an important billing ambiguity to resolve before checkout. The commercial page says its lowest prices are based on 12-month plans paid upfront, while the terms describe prices by plan length as billed every four weeks. Ask for the initial collection, subsequent charge schedule, actual service duration and rules for unused prepaid time. The terms describe the 12-month option as 48 weeks; that is not a calendar year, and the package label does not establish medication supply quantity.

New members on one-month plans receive separate introductory discounts: compounded semaglutide is $99 with insurance initially, then $199, or $179 cash initially, then $289. Compounded tirzepatide is $149 with insurance initially, then $289, or $219 cash initially, then $359. These are first-month offers, not ongoing prices. Use the price questions checklist to request an itemized first charge and renewal amount rather than relying on the smallest number displayed.

Regular compounded-plan rates: advertised monthly amounts, billed every 28 days; confirm upfront collection requirements
Published plan termCompounded semaglutide: insurance / cashCompounded tirzepatide: insurance / cash
1 month$199 / $289$289 / $359
3 months$159 / $249$239 / $309
6 months$129 / $219$209 / $289
12 months$99 / $169$179 / $239
Sources: [10] [12]

Separate insurance for care from coverage for medicine

Found’s “with insurance” label needs careful interpretation. Its terms say the rate reflects coverage for clinical care, while its financial consent makes members responsible for compounded GLP-1 charges and prohibits submitting those charges to their health plan. The subscription fee is also described as a noncovered service. Insurance participation therefore does not mean the insurer pays for the compounded preparation or membership. Ask Found and your insurer separately which clinical services are covered and what patient balances remain.

For both the oral-generics and branded GLP-1 plans, the published insurance rates are $89, $79, $69 and $49 per 28-day cycle for one-, three-, six- and 12-month terms. Cash rates are $149, $139, $129 and $99, respectively. The generics plan includes medication; the branded plan does not. Found’s free coverage checker reports medication-specific coverage, prior-authorization requirements and estimated patient costs when available. It does not request treatment or issue a prescription.

Government coverage requires a separate conversation. General offer terms exclude Medicare, Medicaid, TriCare, MediCal and similar plans from insurance pricing. Yet a Medicare page advertises care for adults ages 65–75 and conditional access to a Medicare GLP-1 Bridge program. Found describes that program as running July 1, 2026, through December 31, 2027, outside ordinary Part D payment flow. These statements do not establish that ordinary insurance-plan prices apply to Medicare members.

Sources: [10] [14] [11] [8]

Find out what the consultation can—and cannot—promise

Found describes starting compounded semaglutide care with a short health assessment, followed by clinician review of medical history, previous weight-management efforts and personal circumstances. Prescribing depends on appropriateness, rather than payment alone. Found says every clinician is board-certified and trained in metabolic medicine; that is a provider statement, not an independent credential check. Its billing consent names Pippen and Cloud medical groups and other potential affiliates. Ask who will treat you and which entity bills for that care.

Eligibility descriptions are not uniform across products. The compounded semaglutide page describes adults who may benefit from weight loss. The compounded tirzepatide page specifies adults with obesity or overweight, a BMI of at least 25 and at least one weight-related condition. Those are Found’s descriptions, not individualized eligibility advice or universal prescribing thresholds. The consulted documentation does not establish one general minimum age for the entire program or a definitive state-by-state availability list.

Found distinguishes medicines approved for obesity from medicines approved for other conditions that its clinicians may prescribe off-label. Ask the clinician to identify the proposed product’s status and explain why it fits the assessment. NIDDK advises discussing current medicines, supplements, allergies, health conditions and pregnancy plans when considering weight-management medication. Bringing those details to the consultation is more useful than treating an advertised eligibility statement as a guarantee that a particular prescription will follow.

Sources: [14] [7] [9] [5] [2]

Clarify who answers after the prescription

Insurance and cash members should expect different consultation formats. Found says insurance-supported care requires synchronous video visits, including before each refill, billed to insurance with a visit copay typically around $30 in addition to the plan price. Cash care is text-based and asynchronous in most cases, with no separate visit copay. Ask how a necessary video visit would be handled under your arrangement, and how scheduling affects a refill when an appointment is required.

The compounded tirzepatide page promises monthly care-team follow-up to review response and address challenges. The semaglutide page says a provider explains injection, storage and disposal, with messaging available between visits. Messaging access is not a documented response-time guarantee. Ask who monitors messages, what happens outside business hours, and where to direct a time-sensitive medication concern. Our support questions guide helps distinguish routine messaging from a clearly defined clinical escalation route.

The compounded-plan terms also list one-to-one health coaching, app-based lifestyle tools and a member community. Found’s pricing page advertises medical, lifestyle and behavioral guidance plus round-the-clock access to Aimee, its AI health companion. That 24/7 availability refers to AI, not continuous human clinical coverage. Before counting coaching as a major benefit, request its scheduling process, contact frequency and scope, and ask which questions must instead go to the prescribing clinician or pharmacist.

Sources: [13] [5] [9] [10] [12]

Request the pharmacy and delivery details

Found says it works exclusively with 503A compounding pharmacies and describes preparation pursuant to individual prescriptions under sterile-preparation standards. It also says compounded semaglutide undergoes third-party potency, purity and sterility testing before shipment. These are commercial representations, not independent verification. The consulted documentation does not name the compounding pharmacies or testing laboratory, or provide certificates of analysis. Ask for the dispensing pharmacy’s identity and a clear route for questions about the particular product you receive.

The terms restrict included compounded medication to fulfillment through a pharmacy facilitated by Found. Branded medicines may instead be filled at a pharmacy of your choice using cash or insurance, or, where eligible, through NovoCare or LillyDirect on a cash-only basis. Found says eligible members receive home shipment and that most can start treatment within a week. That broad statement is not a separate guarantee of clinical review time, dispatch date or arrival date.

Shipping charges, carrier, cold-chain arrangements and package supply were not established in the consulted documentation. Ask who handles a delayed, damaged or temperature-compromised delivery before ordering. FDA explicitly advises not using an injectable GLP-1 medicine that arrives warm or insufficiently refrigerated, and contacting the provider or dispensing pharmacy. Also ask for product-specific administration instructions: FDA has received reports of compounded-medication measurement and administration errors, including some associated with hospitalization.

Sources: [9] [7] [10] [1]

Ask what supports the specific preparation offered

Found discloses that compounded preparations are not FDA approved or evaluated by FDA for safety or effectiveness and are unavailable in some states. FDA approval concerns a specific product, not Found as a clinic or a dispensing pharmacy. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Ask how the clinician applies that distinction to the proposed preparation rather than accepting a general comparison with a brand.

Nonapproval alone does not prove clinical inequivalence, but Found’s pharmacy and testing statements also do not establish that its preparation produces the outcomes of an approved product. Research results for particular studied medicines cannot be assumed to apply to Found’s compounded versions, other routes, microdoses or an individual member. The useful question is what evidence supports the exact treatment being offered and which uncertainties remain—not whether a familiar ingredient name makes every version interchangeable.

Sources: [9] [10] [6] [1] [3] [4]

Settle the exit terms while enrollment is still optional

Found’s membership-refund policy first says a full refund is available if cancellation occurs within three days of the original purchase or before completing the first medical consultation. A subsequent sentence says membership becomes nonrefundable after either event, creating ambiguity about how those milestones interact. Request a written explanation before relying on either condition. Medication and laboratory kits are nonreturnable and nonrefundable once dispensed or shipped, even unused; canceling membership does not reverse those charges.

Medical disqualification from every available treatment option can qualify for a membership refund. Being unable to obtain a preferred GLP-1 does not qualify if other Found options remain available. Renewals are nonrefundable, and Found recommends canceling or pausing at least 48 hours before the scheduled charge. The terms allow up to 30 days for granted refunds; do not treat that as a guaranteed bank-credit date. Operational cancellation steps and treatment of unused prepayments remain questions to settle.

There are additional financial responsibilities beyond subscription renewal. A missed consultation or cancellation with less than 24 hours’ notice carries a $30 fee. Post-claim invoices are due within 15 days, after which Found may charge the card on file; an unsuccessful payment allows another 30 days to resolve the balance before subscription termination. Keep appointment cancellation distinct from subscription cancellation. Our renewal questions guide can help organize the dates, confirmations and remaining obligations.

Sources: [10] [14]

Questions & answers

Does Found’s Medicare page resolve the government-insurance exclusion?

No. It describes a separate, conditional Bridge pathway with a $50 monthly medication copay, apart from Found membership. Found says that copay does not count toward the Part D deductible or out-of-pocket maximum, and Extra Help does not apply. Eligibility is not guaranteed. The page lists Wegovy injections and tablets, Zepbound KwikPen and Foundayo; ask which current pathway and product apply.

Sources: [8] [10]
Are the $99 and $179 compounded prices straightforward cash offers?

Not across all pages. The regular terms associate $99 semaglutide and $179 tirzepatide with 12-month insurance-priced packages including medication, care and membership. The Medicare page describes those starting figures as cash prices with membership separate. Request an itemized offer rather than treating these conflicting descriptions as one confirmed price.

Sources: [10] [8]
What do Found’s branded-plan checkout discounts cover?

The homepage advertises $100 off initial cash-membership checkout supporting branded prescriptions, naming Zepbound vials, Wegovy pens and Wegovy pills. It separately advertises $50 off when Found is in-network with insurance. These are initial-checkout discounts, limited to one redemption per account, exclude Med Kit plans and may change. They do not establish an ongoing medication discount.

Sources: [7]
Can I assume Found serves my state or offers Spanish-language care?

Neither should be assumed. Found says compounded medicines are unavailable in some states, and the consulted geographic modules did not establish a reliable definitive list for each treatment. Spanish-language clinical care, interpretation and a Spanish app were also unconfirmed. Ask about your location, proposed medication and communication needs before paying.

Sources: [10] [9] [5]
Does joining guarantee my preferred GLP-1 prescription?

No. Found describes clinical assessment before prescribing, and its refund policy explicitly distinguishes rejection for one preferred medicine from disqualification for all available treatment options. If alternatives remain available, not receiving your preferred GLP-1 does not itself qualify for a refund. Discuss acceptable options and the applicable refund boundary before completing enrollment.

Sources: [9] [10]
Does Found document immediate access to a human clinician?

No immediate human response commitment was established. Found documents between-visit messaging and monthly follow-up for compounded tirzepatide, but its advertised 24/7 companion is Aimee, an AI service. Ask for human response expectations, the contact route for medication problems and the process when the usual care team is unavailable.

Sources: [9] [5] [12]

Our assessment

Found documents a broad weight-care offering with clinical assessment, several medication pathways, coaching and ongoing digital support. It also publishes more concrete plan rates and financial responsibilities than a headline-only advertisement. The unresolved issues are consequential, however: upfront versus recurring collection, conflicting branded and Medicare price descriptions, pharmacy identification, delivery arrangements and ambiguous refund language. The strongest preparation is a written, individualized plan summary covering the exact product, initial and renewal charges, clinical access, pharmacy and exit rules. Found’s range of options is meaningful, but it should not substitute for clarity about the particular arrangement you would buy.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

  1. FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
  2. NIDDK: prescription medications for overweight and obesity ↗
  3. Wilding et al. (2021): STEP 1 semaglutide trial ↗
  4. Jastreboff et al. (2022): SURMOUNT-1 tirzepatide trial ↗
  5. Found — medication/compounded tirzepatide ↗
  6. Found — microdosing ↗
  7. Found — official website ↗
  8. Found — medicare weight loss ↗
  9. Found — medication/compounded semaglutide ↗
  10. Sesame / Success by Sesame — terms/offer terms v3 ↗
  11. Sesame / Success by Sesame — glp1 checker ↗
  12. Sesame / Success by Sesame — plans and pricing ↗
  13. Sesame / Success by Sesame — insurance ↗
  14. Sesame / Success by Sesame — terms/payment and billing consent ↗

Continue reading